Nanodrops

Minimally Invasive Laser Imprint System for Instant Vision Correction

Health Tech & Life Sciences
Private
Follow

Company Overview

Snapshot

Founded in February 2018 by Vance Thompson, Steve Elbaz, Prof. Moshe Lellouche, David Smadja, and Prof. Zeev Zalevsky, Nanodrops operates with 1–10 employees. The company has completed 2 funding rounds with Sanara Capital and Sanara Ventures as investors.

Business overview

Nanodrops is developing a minimally invasive visual optical correction solution that aims to replace traditional glasses. Its core technology involves a three-step process: refractive pattern calculation, optical pattern creation using superficial laser imprint technology, and the application of specialized eye drops. The company serves the healthcare market, specifically targeting patients requiring vision correction, and operates within the Health Tech & Life Sciences sector, focusing on medical treatment and therapeutics.

Strategic signal

In April 2025, Nanodrops appointed Daria Lemann-Blumenthal as its new CEO. This leadership change signals a strategic move to potentially accelerate the company's development and commercialization efforts for its vision correction technology, indicating a focus on strengthening executive leadership as it advances its product.

Log in to access full profile

Company Intelligence Q&A

What is Nanodrops' core technology?
Nanodrops is developing a minimally invasive visual optical correction solution based on superficial laser imprint technology and specialized eye drops. This system is designed to correct vision without the need for traditional glasses.
When was Nanodrops founded and by whom?
Nanodrops was founded in February 2018 by Vance Thompson, Steve Elbaz, Prof. Moshe Lellouche, David Smadja, and Prof. Zeev Zalevsky.
Has Nanodrops recently appointed a new CEO?
Yes, in April 2025, Nanodrops announced the appointment of Daria Lemann-Blumenthal as its new CEO.
Log in to access full profile